FOR LABORATORY RESEARCH USE ONLY Not for human or veterinary use
View catalog ↗
Menu

THE DOCUMENT LIBRARY

Certificates of analysis.

Original supplied laboratory reports and supplier documents, organized by compound and sample strength.

24 supplied documents

Supplier document · DOCX

KPV Bulk material

Manufactured Sep 26, 2026

Supplier specifications; no finished-vial strength is specified.

Supplier document · DOCX

MOTS-c Bulk material

See original document

Supplier specifications; no finished-vial strength is specified.

Supplier document · DOCX

NAD+ Bulk material

See original document

The source document contains an expiry date preceding its manufacture date. Check the original and request clarification.

Supplier document · DOCX

Reta Bulk material

Reported Sep 10, 2026

Retatrutide bulk-material report; not a 10 mg finished-vial certificate.

Supplier document · DOCX

Semax Bulk material

Manufactured Aug 16, 2026

Supplier specifications; no finished-vial strength is specified.

Supplier document · DOCX

Tesamorelin Bulk material

Analyzed Aug 21, 2026

Supplier specifications; no finished-vial strength is specified.

Supplier document · DOCX

Tirzepatide Bulk material

Manufactured Aug 23, 2026

Supplier specifications; no finished-vial strength is specified.

AOD9604 10 mg — BTLabs supplied report

BTLabs · JPG

AOD9604 10 mg

Aug 5, 2026

Screenshot supplied; page 2 is only partly visible. This is a 10 mg sample, while the catalog lists 5 mg.

BPC-157 + Thymosin beta-4 10 mg blend — Freedom Diagnostics supplied report

Freedom Diagnostics · JPG

BPC-157 + Thymosin beta-4 10 mg blend

Aug 23, 2026

Report label: Wolverine 10mg. Identity is BPC-157 / Thymosin beta-4; do not assume equivalence with another blend.

Reta 10 mg — Freedom Diagnostics supplied report

Freedom Diagnostics · JPG

Reta 10 mg

Aug 23, 2026

Report label: GLP3-RT 10mg; lot RT10-2026-003.

Reta 20 mg — Freedom Diagnostics supplied report

Freedom Diagnostics · JPG

Reta 20 mg

Jul 28, 2026

Reference report for a strength not currently listed in the catalog.

Reta 20 mg — Janoshik supplied report

Janoshik · JPG

Reta 20 mg

Aug 17, 2026

Report #215545; batch 258014. Reference strength not currently listed.

Reta 30 mg — Janoshik supplied report

Janoshik · JPG

Reta 30 mg

Jun 18, 2026

Report #167212; batch 2026-06. Reference strength not currently listed.

Tesamorelin 10 mg — BTLabs supplied report

BTLabs · JPG

Tesamorelin 10 mg

Aug 5, 2026

Screenshot supplied; page 2 is only partly visible.

Tirzepatide 20 mg — Janoshik supplied report

Janoshik · JPG

Tirzepatide 20 mg

Jun 18, 2026

Report #167196; batch 2026-06. Reference strength not currently listed.

Tirzepatide 30 mg — Freedom Diagnostics supplied report

Freedom Diagnostics · JPG

Tirzepatide 30 mg

Jul 28, 2026

Report label: Tirzepatide 30mg; lot Red Cap.

Tirzepatide 50 mg — Freedom Diagnostics supplied report

Freedom Diagnostics · JPG

Tirzepatide 50 mg

Jul 28, 2026

Report label: Tirzepatide 50mg; reference strength not currently listed.

PEPTIDE EXPRESS

LABORATORY RESEARCH USE ONLY

Before you enter

You must be 18 years of age or older to enter this website.

Research only

All products are supplied exclusively for laboratory research. Not for human or animal consumption. Not for medical or veterinary use.

Confirmation applies to this browsing session.